Deepening Exchanges and Pursuing Cooperation, Joining Hands to Open Up New Markets — Changchun Clients Visit Jilin Province Zhongke Jingyan Health Industry Group for Inspection and Negotiations on Collaboration Regarding the HPV Product Line
Published Time:
2026-08-06
On August 5, a delegation of clients from Changchun paid a visit to Jilin Zhongke Jingyan Health Industry Group for an on-site inspection. The two sides engaged in in-depth business discussions centered on the HPV product line, holding pragmatic talks on product collaboration, market channels, and operational implementation, thereby laying a solid foundation for future project cooperation.
On August 5, a delegation of customers from Changchun paid a visit. Jilin Province Zhongke Jingyan Health Industry Group Field visits were conducted, during which both parties engaged in in-depth business discussions on the HPV product series. They held pragmatic talks on product collaboration, market channels, and operational implementation, laying a solid foundation for future project cooperation.
Accompanied by relevant officials from the Group, the visiting clients toured the company’s product exhibition hall, R&D laboratories, production workshops, and quality‑inspection facilities. On‑site staff provided a detailed overview of the Group’s development history, R&D capabilities, manufacturing qualifications, and quality‑control system, with particular emphasis on the formulation and manufacturing processes of the HPV‑related product line, its competitive advantages, regulatory filings, production capacity, and clinical application scenarios. They also offered a clear, hands‑on demonstration of the Group’s end‑to‑end standardized management—from raw‑material sourcing and processing to finished‑product inspection. The visitors closely observed the production floor and expressed strong appreciation for the Group’s comprehensive industrial support infrastructure and its rigorous production‑control capabilities.
Following the tour, both parties convened a dedicated business‑to‑business meeting. During the session, the Zhongke Jingyan team provided a detailed presentation on the technical features of the HPV product line, supply‑chain models, OEM/ODM collaboration frameworks, and market‑support policies, while also analyzing the products’ market prospects and commercialization pathways in light of current industry trends. In turn, the visiting clients outlined their cooperation aspirations, drawing on their channel networks and market‑operation expertise. The two sides engaged in an open and candid exchange of views on key issues—including product selection, delivery timelines, joint channel development, marketing initiatives, and risk management—conducting in‑depth discussions on a range of viable, implementable collaboration models.
Both parties unanimously agreed that the market demand for HPV‑related health products is substantial, that their respective resources are highly complementary, and that they enjoy a strong foundation for cooperation. The visiting client stated that, through this on‑site visit, they gained a tangible sense of Zhongke Jingyan Health Industry Group’s robust R&D and manufacturing capabilities in the medical device and health product sectors, and expressed full confidence in the HPV product line. They look forward to leveraging their own channel strengths to achieve resource synergy and mutually beneficial outcomes.
The group’s head stated that the company will continue to strengthen its product R&D and manufacturing capabilities, maintain rigorous quality control, and look forward to further refining collaboration plans, advancing project implementation, jointly expanding into new markets, and working together to deliver high‑quality, health‑focused products to consumers.
This visit, which included fact-finding and business talks, has established an efficient platform for commercial collaboration, further expanding the Group’s market‑partnership footprint. Moving forward, Jilin Province Zhongke Jingyan Health Industry Group will remain committed to innovation‑driven growth, underpinned by high‑quality products, while proactively forging partnerships with premier collaborators to create synergies and achieve mutually beneficial development.
Latest News
